Genevant Competitors and Similar CompaniesClear all
Genevant's competitors and similar companies include AmacaThera, Monte Rosa Therapeutics and Cell Genesys.
 Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. |  AmacaThera AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications. |  Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. |  Cell Genesys Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today. | |
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 2018 | Founding Date 1988 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations New York, US HQ | Locations Toronto, CA HQ Toronto, CA | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US | Locations Roosevelt, US HQ |
Employees | Employees 524% decrease | Employees 12 | Employees 75 | Employees 89 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 6.1m | Total funding raised $ 223.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AmacaThera
HQ
Toronto, CA
Employees
12
AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications.
View companyMonte Rosa Therapeutics
HQ
Boston, US
Employees
75
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View companyCell Genesys
HQ
Roosevelt, US
Employees
89
Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.
View company